pembrolizumab,gemcitabine,cisplatin
merck
['kn966']
 the important difference here is the following: topaz achieved the same clinical outcome (and a difference in orr) with an #immunotherapy only maintenance while kn966 kept ctx going.
Oncologist focused on #PrecisionOncology 🎯 & #PancreaticCancer 💜 •@myesmo faculty• #MissionCancer Board🇪🇺•Rolling with @OncoAlert 🚨 •Views are my own•